Lemaître Vascular Inc. Files 2024 10-K
Ticker: LMAT · Form: 10-K · Filed: Feb 28, 2025 · CIK: 1158895
| Field | Detail |
|---|---|
| Company | Lemaitre Vascular Inc (LMAT) |
| Form Type | 10-K |
| Filed Date | Feb 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, medical-devices
Related Tickers: LMAV
TL;DR
LMAV 2024 10-K filed. Full year financials out.
AI Summary
Lemaître Vascular Inc. filed its 2024 10-K on February 28, 2025, reporting on its fiscal year ending December 31, 2024. The company, a manufacturer of surgical and medical instruments, is based in Burlington, MA. The filing covers its financial performance and business operations for the year.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Lemaître Vascular's financial health and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: low — This is a standard annual financial filing with no immediate red flags.
Key Players & Entities
- LEMAITRE VASCULAR INC (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 2025-02-28 (date) — Filing Date
- Burlington, MA (location) — Company Address
- 3841 (industry_code) — Standard Industrial Classification
FAQ
What was Lemaître Vascular Inc.'s total revenue for the fiscal year ending December 31, 2024?
The provided text does not contain specific revenue figures for the fiscal year ending December 31, 2024.
What is Lemaître Vascular Inc.'s primary business segment?
Lemaître Vascular Inc. is in the business of manufacturing Surgical & Medical Instruments & Apparatus, with SIC code 3841.
When was the 10-K filing submitted to the SEC?
The 10-K filing was submitted on February 28, 2025.
Where is Lemaître Vascular Inc. headquartered?
Lemaître Vascular Inc. is headquartered at 63 Second Avenue, Burlington, MA 01803.
What is the SEC file number for Lemaître Vascular Inc.'s 10-K filing?
The SEC file number for this 10-K filing is 001-33092.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 28, 2025 regarding LEMAITRE VASCULAR INC (LMAT).